Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside

S. Faraj 1 M. Bahri 1 S. Fougeray 1 A. El Roz 1 J. Fleurence 1 J. Véziers 2 M. D. Leclair E. Thebaud 3 F. París 1 Stéphane Birklé 1
1 CRCINA - Centre de recherche de Cancérologie et d'Immunologie / Nantes - Angers
2 RMeS - Regenerative Medicine and Skeleton research lab
3 CHU Nantes - Centre hospitalier universitaire de Nantes
Document type :
Journal articles
Complete list of metadatas
https://www.hal.inserm.fr/inserm-01596068
Contributor : Elizabeth Bernardo <>
Submitted on : Wednesday, September 27, 2017 - 10:59:08 AM
Last modification on : Tuesday, October 15, 2019 - 1:05:49 AM

Links full text

pubmedcentral

Identifiers

Collections

UNIV-ANGERS | UNIV-NANTES | CRCINA | RMES | UNAM

Citation

S. Faraj, M. Bahri, S. Fougeray, A. El Roz, J. Fleurence, et al.. Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside. OncoImmunology, Taylor & Francis, 2018, 7 (1), ⟨10.1080/2162402X.2017.1373232⟩. ⟨inserm-01596068⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

132

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD